Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Poll

February 24, 2014

Drugmaking in India

The FDA Commissioner recently traveled to India to express the agency’s reservations over shortcomings involving the processes used by several of India’s drug manufacturers. The visit also highlighted the challenges Washington perceives from India’s growing domestic biopharma industry. (For more on the visit, click here.)

Do you think the U.S. concern over pharmaceutical manufacturing operations in India might be more motivated by competitive issues rather than quality control problems?

  {{ choice.Percent }}%